Anticancer activity of sodium propionate in hepatocellular carcinoma cells via downregulation of HDAC2 and HDAC6
Journal of Computer-Aided Molecular Design · 06.11.2026 · 40 (1)
DOI: 10.1007/s10822-026-00967-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Computer-Aided Molecular Design, online erschienen am 06.11.2026. Verfasst von Ganapati Pakkirappa Yadav und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Sahyadri Science College, Kuvempu University, Shivamogga, Karnataka, 577 203, India. Hauptthemen laut MEDLINE: Histone Deacetylase 2, Carcinoma, Hepatocellular, Liver Neoplasms, Propionates. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Manipal Academy of Higher Education, Manipal.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is an aggressive malignancy driven by epigenetic dysregulation. This study investigates the anticancer potential of sodium propionate (SP) as an epigenetic modulator targeting histone deacetylases (HDACs) using an integrated in silico and in vitro approach. Bioinformatics analyses were conducted using publicly available HCC transcriptomic datasets from GEO database, disease gene database (GeneCards database), and chemical-gene interaction networks (Comparative Toxicogenomic Database) to identify potential therapeutic targets, HDAC2 and HDAC6 as key therapeutic targets in HCC. Computational ADMET screening indicated SP possesses favourable drug-likeness, high oral bioavailability, and low toxicity. Molecular docking and 500-ns molecular dynamics simulations showed stable SP binding to HDAC2, with ligand RMSD of 1.5-2.0 Å, protein RMSD of 3.0-4.5 Å, and active-site RMSF < 1.0 Å, supported by persistent Zn²⁺ coordination and hydrophobic interactions. In vitro evaluations in HepG2 cells revealed distinct dose-dependent cytotoxicity (IC₅₀ = 8.2 mM) and pronounced morphological alterations. Furthermore, SP treatment strongly downregulated the mRNA expression of HDAC2 (0.31-fold, p < 0.001) and HDAC6 (0.60-fold, p < 0.05). This suppression was accompanied by a significant, dose-dependent increase in caspase-3/7 activity, confirming apoptotic induction. These findings suggest SP functions as a dual-action epigenetic modulator in HCC, promoting apoptosis by downregulating HDAC2/6 expression and potentially inhibiting their enzymatic activity. However, biochemical assays, protein-level validation, and in vivo HCC models are necessary to validate this inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Sahyadri Science College, Kuvempu University, Shivamogga, Karnataka, 577 203, India.
- Department of Biotechnology, Jnana Sahyadri, Kuvempu University, Shankaraghatta, Karnataka, 577 451, India.
- NITTE (Deemed to be University), Nitte University Center for Science Education and Research, Deralakatte, Mangalore, Karnataka, 575018, India.
- Department of Bioinformatics and Biostatistics, NITTE (Deemed to be University), Nitte University Center for Science Education and Research (NUCSER), Panner campus, Deralakatte, Mangalore, Karnataka, 575018, India.
- Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, India.
- Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, India. ravindranath.bs@manipal.edu.
Förderung
- Manipal Academy of Higher Education, Manipal
Zitieren
APA
Yadav, G. P., Krishnappa, P., M, K. H., Sangamesh, V. C., Gollapalli, P., K, S., & Bilachi, R. S. (2026). Anticancer activity of sodium propionate in hepatocellular carcinoma cells via downregulation of HDAC2 and HDAC6. Journal of Computer-Aided Molecular Design, 40(1). https://doi.org/10.1007/s10822-026-00967-3
Vancouver
Yadav GP, Krishnappa P, M KH, Sangamesh VC, Gollapalli P, K S, et al. Anticancer activity of sodium propionate in hepatocellular carcinoma cells via downregulation of HDAC2 and HDAC6. Journal of Computer-Aided Molecular Design. 2026;40(1). doi:10.1007/s10822-026-00967-3
BibTeX
@article{Yadav2026,
author = {Yadav, Ganapati Pakkirappa and Krishnappa, Pradeepa and M, Kumaraswamy H and Sangamesh, Vinay C and Gollapalli, Pavan and K, Sapna and Bilachi, Ravindranath S},
title = {Anticancer activity of sodium propionate in hepatocellular carcinoma cells via downregulation of HDAC2 and HDAC6},
journal = {Journal of Computer-Aided Molecular Design},
year = {2026},
volume = {40},
number = {1},
doi = {10.1007/s10822-026-00967-3}
}
EUVIMED